Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy

Annelies W. Turksma; Veerle M. H. Coupe; Marc C. Shamier; Kevin L. H. Lam; Vincent A. de Weger; Jeroen A. M. Belien; Alfons J. van den Eertwegh; Gerrit A. Meijer; Chris J. L. M. Meijer; Erik Hooijberg

doi:10.1158/1078-0432.CCR-13-2462

Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy

Annelies W. Turksma, Veerle M. H. Coupe, Marc C. Shamier, Kevin L. H. Lam, Vincent A. de Weger, Jeroen A. M. Belien, Alfons J. van den Eertwegh, Gerrit A. Meijer, Chris J. L. M. Meijer, Erik Hooijberg

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	346-356
Journal	Clinical Cancer Research
Volume	22
Issue number	2
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-2462
Publication status	Published - 15 Jan 2016

Access to Document

10.1158/1078-0432.CCR-13-2462

Cite this

Turksma, A. W., Coupe, V. M. H., Shamier, M. C., Lam, K. L. H., de Weger, V. A., Belien, J. A. M., ... Hooijberg, E. (2016). Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy. Clinical Cancer Research, 22(2), 346-356. https://doi.org/10.1158/1078-0432.CCR-13-2462

Turksma, Annelies W. ; Coupe, Veerle M. H. ; Shamier, Marc C. ; Lam, Kevin L. H. ; de Weger, Vincent A. ; Belien, Jeroen A. M. ; van den Eertwegh, Alfons J. ; Meijer, Gerrit A. ; Meijer, Chris J. L. M. ; Hooijberg, Erik. / Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy. In: Clinical Cancer Research. 2016 ; Vol. 22, No. 2. pp. 346-356.

@article{0b7e5f0ae1764db98885c8a708edb867,

title = "Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy",

author = "Turksma, {Annelies W.} and Coupe, {Veerle M. H.} and Shamier, {Marc C.} and Lam, {Kevin L. H.} and {de Weger}, {Vincent A.} and Belien, {Jeroen A. M.} and {van den Eertwegh}, {Alfons J.} and Meijer, {Gerrit A.} and Meijer, {Chris J. L. M.} and Erik Hooijberg",

year = "2016",

month = "1",

day = "15",

doi = "10.1158/1078-0432.CCR-13-2462",

language = "English",

volume = "22",

pages = "346--356",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "2",

}

Turksma, AW, Coupe, VMH, Shamier, MC, Lam, KLH, de Weger, VA, Belien, JAM , van den Eertwegh, AJ, Meijer, GA, Meijer, CJLM & Hooijberg, E 2016, 'Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy', Clinical Cancer Research, vol. 22, no. 2, pp. 346-356. https://doi.org/10.1158/1078-0432.CCR-13-2462

Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy. / Turksma, Annelies W.; Coupe, Veerle M. H.; Shamier, Marc C.; Lam, Kevin L. H.; de Weger, Vincent A.; Belien, Jeroen A. M.; van den Eertwegh, Alfons J.; Meijer, Gerrit A.; Meijer, Chris J. L. M.; Hooijberg, Erik.

In: Clinical Cancer Research, Vol. 22, No. 2, 15.01.2016, p. 346-356.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy

AU - Turksma, Annelies W.

AU - Coupe, Veerle M. H.

AU - Shamier, Marc C.

AU - Lam, Kevin L. H.

AU - de Weger, Vincent A.

AU - Belien, Jeroen A. M.

AU - van den Eertwegh, Alfons J.

AU - Meijer, Gerrit A.

AU - Meijer, Chris J. L. M.

AU - Hooijberg, Erik

PY - 2016/1/15

Y1 - 2016/1/15

U2 - 10.1158/1078-0432.CCR-13-2462

DO - 10.1158/1078-0432.CCR-13-2462

M3 - Article

C2 - 26420855

VL - 22

SP - 346

EP - 356

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 2

ER -